Chengdu, China

Wei Qi

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 14.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wei Qi - Innovator in Pharmaceutical Chemistry

Introduction

Wei Qi is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug compounds. His work focuses on addressing critical health issues through novel therapeutic approaches.

Latest Patents

Wei Qi holds 2 patents, with his latest inventions centered around azetidine derivatives. These derivatives are designed for use as Janus kinase (JAK) inhibitors. The patents detail a preparation method for these compounds and their application in treating JAK-related diseases, including inflammatory diseases, autoimmune diseases, and cancers.

Career Highlights

Throughout his career, Wei Qi has worked with notable companies in the biopharmaceutical sector. He has been associated with Sichuan Kelun Biotech Biopharmaceutical Co., Ltd. and Chengdu Di'ao Pharmaceutical Group Co., Ltd. His expertise in drug development has positioned him as a key player in the industry.

Collaborations

Wei Qi has collaborated with esteemed colleagues, including Yinong Xie and Zejin You. These partnerships have fostered innovation and contributed to the advancement of pharmaceutical research.

Conclusion

Wei Qi's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to impact the development of treatments for various diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…